Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-247-3 | CAS number: -
LD50 oral = 1410 mg/kg bw
Mortality: number of deaths at each dose: 2/5, 3/5 and 4/5 at 1250, 1600 and 2000 mg/kg for females, and 2/5 at 2000 mg/kg for males.
Time of death was Day 1 for all but one animal at 1600 mg/kg that died on day 13.
Clinical signs: hypoactivity, hunched posture, irregular breathing were observed in all animals from all dose groups on day 1 and was reversible within 3 days for males at 2000 mg/kg. For females, the above symptoms plus abnormal gait, ptosis and piloerection were seen in all animals at 1600 and 2000 mg/kg and were not reversible.
Necropsy findings: Red discolouration of the GI tract filled with blood, white discolouration of the mucosa of the stomach and intestine, pale adrenals, growing together of the stomach and nearby organs, stomach haemorrhages and abdomen filled with fluid (in animals that died).
The key study is a 1988 GLP guideline study of male and female rats exposed by oral gavage to toluene-4-sulphonic acid (CAS No, 104-15-4). The LD50 value was 1410 mg/kg bw. Given the predominance of deaths occurring within the day of exposure and the necropsy findings, it is likely that the deaths were a result of the acidity / corrosivity of the test substance. The internal examination findings (e.g., GI tract filled with blood; stomach haemorrhages and abdomen filled with fluid) suggest a secondary effect (i.e., corrosion) rather than a chemical toxicity.
In addition to the key study, there are 2 supporting acute oral studies a 1977 test of xylenesulphonic acid (CAS No. 25321-41-9) and a 1962 published study of benzenesulphonic acid (CAS No. 98-11-3). Both of these studies, as well as two additional published studies support the LD50 value of 1410 mg/kg bw reported in the key study.
There are not data for dermal acute toxicity. The aromatic sulphonic acids are corrosive and therefore with regard to animal welfare, dermal studies are not recommended. There are however acute dermal toxcity studies for the closely related hyrotropes that are the salt form of the sulphonic acids. The LD50 for the salts is >2000 mg/kg bw.
A single acute inhalation study concluded the acids are harmful at saturated air conditions as 3 of 6 animals died. A concentration was not reported.
Since it is not possible to directly assess the toxicity of sulphonic acids due to the corrosion/irritation effects, read-across from the hydrotopes resdults could be taken into account.
The studies with the salts (hydrotropes) provide valid read-across for the acids. The specific cation is not expected to have an appreciable effect on fate, ecotoxicity or mammalian toxicity and therefore the dataset for the entire hydrotropes category can be applied broadly.
The aromatic sulphonic acids are almost completely ionized in watery environments even at low pH. The salts of these acids are the hydrotropes (or “sulphonates”) which include ammonium, calcium, potassium and sodium cations. In principle the salts get dissociated when in contact with water, so forming back to the acids. Because of their close chemical similarities and because much of the production of the aromatic sulphonic acids goes to manufacturing the salts, the extensive dataset for the hydrotropes can also be used as a source of read-across for endpoints in an aromatic sulphonic acid dossier. This is particularly relevant for studies that are conducted in water (e.g., ecotoxicity and biodegradation) as well as for mammalian toxicity studies where the relatively high acidity of the acid form has an immediate and harsh local effect, whereas the salt form provides an indication of potential systemic toxicity beyond the site of application or initial contac
No basis for acute toxicity classification is found.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again